GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Consort Medical PLC (GREY:CSRMF) » Definitions » Capex-to-Revenue

Consort Medical (Consort Medical) Capex-to-Revenue : 0.05 (As of Oct. 2019)


View and export this data going back to . Start your Free Trial

What is Consort Medical Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Consort Medical's Capital Expenditure for the six months ended in Oct. 2019 was $-9.37 Mil. Its Revenue for the six months ended in Oct. 2019 was $184.81 Mil.

Hence, Consort Medical's Capex-to-Revenue for the six months ended in Oct. 2019 was 0.05.


Consort Medical Capex-to-Revenue Historical Data

The historical data trend for Consort Medical's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consort Medical Capex-to-Revenue Chart

Consort Medical Annual Data
Trend Apr10 Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.08 0.06 0.07 0.08

Consort Medical Semi-Annual Data
Apr10 Oct10 Apr11 Oct11 Apr12 Oct12 Apr13 Oct13 Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.08 0.05 0.10 0.05

Competitive Comparison of Consort Medical's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, Consort Medical's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consort Medical's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Consort Medical's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Consort Medical's Capex-to-Revenue falls into.



Consort Medical Capex-to-Revenue Calculation

Consort Medical's Capex-to-Revenue for the fiscal year that ended in Apr. 2019 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-30.729) / 397.266
=0.08

Consort Medical's Capex-to-Revenue for the quarter that ended in Oct. 2019 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-9.367) / 184.81
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Consort Medical  (GREY:CSRMF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Consort Medical Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Consort Medical's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Consort Medical (Consort Medical) Business Description

Traded in Other Exchanges
N/A
Address
Breakspear Way, Suite B Breakspear Park, Hemel Hempstead, Hertfordshire, GBR, HP2 4TZ
Consort Medical PLC is part of the healthcare sector in the United Kingdom. It is one of the leading contract manufacturers in the field of drug delivery devices. Its core products include an inhaler, auto-injector, nasal and ocular technologies which it supplies to pharmaceutical companies. Along with devices, the company also specializes in drugs including active pharmaceutical ingredients and finished dose formulations.

Consort Medical (Consort Medical) Headlines

No Headlines